Drug recall
Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1…
FDA recall event 72181 · Class III · Ferring Pharmaceuticals Inc
Key facts
| Event ID | 72181 |
|---|---|
| Recall numbers | D-0015-2016 |
| Recalling firm | Ferring Pharmaceuticals Inc |
| Product type | Drugs |
| Products | Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (contains 5 single dose vials of Bravelle, 5 single dose vials of 0.9% Sodium… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Subpotent Drug |
| Initiation date | Sep 9, 2015 |
| Report date | Oct 21, 2015 |
| Termination date | Nov 18, 2020 |
| City | Parsippany |
| State | NJ |
| Country | United States |
| FEI number | 1000119907 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: